Coexpression cluster:C375
From FANTOM5_SSTAR
Full id: C375_optic_Cardiac_occipital_hippocampus_amygdala_heart_vagina
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0031895 | V1B vasopressin receptor binding | 6.82805122742316e-07 |
GO:0031855 | oxytocin receptor binding | 6.82805122742316e-07 |
GO:0050891 | body fluid osmoregulation | 6.82805122742316e-07 |
GO:0031893 | vasopressin receptor binding | 1.02416748363524e-06 |
GO:0005185 | neurohypophyseal hormone activity | 1.02416748363524e-06 |
GO:0031894 | V1A vasopressin receptor binding | 1.02416748363524e-06 |
GO:0018987 | osmoregulation | 8.19173195646287e-06 |
GO:0005184 | neuropeptide hormone activity | 0.000135030968425998 |
GO:0001664 | G-protein-coupled receptor binding | 0.00121415974217814 |
GO:0050878 | regulation of body fluid levels | 0.00157986801149862 |
GO:0042392 | sphingosine-1-phosphate phosphatase activity | 0.00210868843860719 |
GO:0030816 | positive regulation of cAMP metabolic process | 0.00226678572039262 |
GO:0006670 | sphingosine metabolic process | 0.00226678572039262 |
GO:0006667 | sphinganine metabolic process | 0.00226678572039262 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 0.00226678572039262 |
GO:0045981 | positive regulation of nucleotide metabolic process | 0.00226678572039262 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 0.00226678572039262 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 0.00226678572039262 |
GO:0030810 | positive regulation of nucleotide biosynthetic process | 0.00226678572039262 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 0.00226678572039262 |
GO:0005179 | hormone activity | 0.00226678572039262 |
GO:0051496 | positive regulation of stress fiber formation | 0.00289919055618893 |
GO:0051495 | positive regulation of cytoskeleton organization and biogenesis | 0.00289919055618893 |
GO:0032233 | positive regulation of actin filament bundle formation | 0.00289919055618893 |
GO:0048878 | chemical homeostasis | 0.00368039417526195 |
GO:0030817 | regulation of cAMP biosynthetic process | 0.0039985303853693 |
GO:0003091 | renal water homeostasis | 0.0039985303853693 |
GO:0030146 | diuresis | 0.0039985303853693 |
GO:0017166 | vinculin binding | 0.0039985303853693 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 0.00409243273910375 |
GO:0051492 | regulation of stress fiber formation | 0.00409243273910375 |
GO:0030808 | regulation of nucleotide biosynthetic process | 0.00409243273910375 |
GO:0032231 | regulation of actin filament bundle formation | 0.00409243273910375 |
GO:0030814 | regulation of cAMP metabolic process | 0.00409243273910375 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 0.00438718911543101 |
GO:0043149 | stress fiber formation | 0.00438718911543101 |
GO:0030104 | water homeostasis | 0.00438718911543101 |
GO:0007567 | parturition | 0.00475659573642449 |
GO:0043410 | positive regulation of MAPKKK cascade | 0.00475659573642449 |
GO:0003014 | renal system process | 0.00521716056497323 |
GO:0042592 | homeostatic process | 0.00552056104825354 |
GO:0006140 | regulation of nucleotide metabolic process | 0.00552056104825354 |
GO:0006833 | water transport | 0.00579633313918826 |
GO:0042044 | fluid transport | 0.00579633313918826 |
GO:0051130 | positive regulation of cellular component organization and biogenesis | 0.00721225905871929 |
GO:0043408 | regulation of MAPKKK cascade | 0.00755909920924628 |
GO:0042310 | vasoconstriction | 0.00789113665704299 |
GO:0007589 | fluid secretion | 0.00869181253526654 |
GO:0051017 | actin filament bundle formation | 0.00880731442979931 |
GO:0006171 | cAMP biosynthetic process | 0.00880731442979931 |
GO:0046058 | cAMP metabolic process | 0.00999665889986511 |
GO:0005925 | focal adhesion | 0.015011611682781 |
GO:0000267 | cell fraction | 0.015011611682781 |
GO:0046519 | sphingoid metabolic process | 0.015011611682781 |
GO:0005924 | cell-substrate adherens junction | 0.015435742176374 |
GO:0065008 | regulation of biological quality | 0.015435742176374 |
GO:0048522 | positive regulation of cellular process | 0.015435742176374 |
GO:0009190 | cyclic nucleotide biosynthetic process | 0.015435742176374 |
GO:0030055 | cell-matrix junction | 0.015435742176374 |
GO:0007015 | actin filament organization | 0.015435742176374 |
GO:0007588 | excretion | 0.015435742176374 |
GO:0035150 | regulation of tube size | 0.015435742176374 |
GO:0050880 | regulation of blood vessel size | 0.015435742176374 |
GO:0003018 | vascular process in circulatory system | 0.0155556468794977 |
GO:0005102 | receptor binding | 0.0162484472590287 |
GO:0048518 | positive regulation of biological process | 0.0167667441072256 |
GO:0009187 | cyclic nucleotide metabolic process | 0.0172727118713187 |
GO:0005912 | adherens junction | 0.0183769505943518 |
GO:0051493 | regulation of cytoskeleton organization and biogenesis | 0.0185114408611819 |
GO:0033043 | regulation of organelle organization and biogenesis | 0.0185114408611819 |
GO:0006950 | response to stress | 0.020506881207144 |
GO:0006665 | sphingolipid metabolic process | 0.0218422042088823 |
GO:0009891 | positive regulation of biosynthetic process | 0.0221746544257607 |
GO:0035239 | tube morphogenesis | 0.0258463519980026 |
GO:0005200 | structural constituent of cytoskeleton | 0.0258463519980026 |
GO:0016323 | basolateral plasma membrane | 0.0258463519980026 |
GO:0051128 | regulation of cellular component organization and biogenesis | 0.0299926897886429 |
GO:0031589 | cell-substrate adhesion | 0.0304923716384611 |
GO:0007165 | signal transduction | 0.0306487966665124 |
GO:0035295 | tube development | 0.033750160244109 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 0.0361665252615426 |
GO:0007154 | cell communication | 0.0369427395620263 |
GO:0000165 | MAPKKK cascade | 0.0416447144289407 |
GO:0009967 | positive regulation of signal transduction | 0.0419663592318712 |
GO:0008015 | blood circulation | 0.0428525175398149 |
GO:0003013 | circulatory system process | 0.0428525175398149 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
POLR3G#10622 | 1 | 74.9805273833671 | 0.0132522794323847 | 0.046880561312835 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.